PulteGroup (PHM) Receives a Buy from UBS
UBS analyst John Lovallo maintained a Buy rating on PulteGroup (PHM – Research Report) yesterday and set a price target of $151.00. The ...
Transport Topics5h
Tariff Fears Hit Autos, Chipmakers, China-Exposed Stocks
The threat of tariffs has loomed large over U.S. equities. Investors and strategists warn that high levies can reignite ...
Autos, Chipmakers, China Stocks Brace for Impact as Tariffs Loom
US stocks slipped on Friday afternoon, with carmakers and Chinese companies leading the decline, as the White House said ...
RBC Capital lifts Celestica stock target to $140, keeps Outperform
RBC Capital Markets increased its price target on Celestica (NYSE:CLS) shares from $115.00 to $140.00 while maintaining an Outperform rating. Currently trading at $131.66, near its 52-week high, ...
Q2 2025 Resmed Inc Earnings Call
Welcome to the Q2 fiscal-year 2025 ResMed earnings conference call. My name is Matt and I'll be your operator for today's call. (Operator Instructions) Please note that this conference call is being ...
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...
ResMed upgraded to Buy at UBS as risks skew positive, consensus too cautious
UBS upgraded ResMed (RMD) to Buy from Neutral with a price target of $290, up from $255. The firm thinks consensus is too cautious in the ...
A Glimpse Into The Expert Outlook On Hershey Through 20 Analysts
The 12-month price targets, analyzed by analysts, offer insights with an average target of $162.95, a high estimate of ...